SIGA Technologies Inc.
$3.14
Market Cap
$219.14M
Shares Outstanding
71.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 9, 1997
Round Lot
100
Locale
US
Day Open
$3.03
Day High
$3.20
Day Low
$3.00
Volume
743.7K
VWAP
$3.13
Prev Close
$3.05
Transactions
--
Acc. Volume
--
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
SIGA Technologies Inc. (SIGA) closed the 2026-09-18 session at $3.14, up 2.95% versus the previous close (+0.09). The stock opened at $3.03 and traded between $3.00 and $3.20 during that session. Session trading volume was 744K shares. The volume-weighted average price (VWAP) is $3.13.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
SIGA Technologies Inc. has a market capitalization of $219.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SIGA is listed on the XNAS exchange. The company employs approximately 49 people. SIGA Technologies Inc. is headquartered in NEW YORK, NY. The recorded listing date is 1997-09-09.
On this page you can find market SIGA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.